These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37436560)

  • 1. Predictive Role of a Novel Ferroptosis-Related lncRNA Pairs Model in the Prognosis of Papillary Thyroid Carcinoma.
    Xiao W; Lai Y; Yang H; Que H
    Biochem Genet; 2024 Apr; 62(2):775-797. PubMed ID: 37436560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
    Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
    BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer.
    Xia M; Wang S; Wang L; Mei Y; Tu Y; Gao L
    Front Endocrinol (Lausanne); 2023; 14():1062317. PubMed ID: 37025405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
    Chen F; Li Z; Deng C; Yan H
    J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
    Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Ferroptosis-Related Long Non-Coding RNA Risk Model Predicts the Prognosis of Patients With Papillary Thyroid Cancer.
    Zhao JY; Yao JM; Zhang XZ; Wang KL; Jiang S; Guo SY; Sheng QQ; Liao L; Dong JJ
    World J Oncol; 2024 Aug; 15(4):648-661. PubMed ID: 38993258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.
    Qian X; Tang J; Li L; Chen Z; Chen L; Chu Y
    Bioengineered; 2021 Dec; 12(1):2341-2351. PubMed ID: 34077308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
    Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
    Front Immunol; 2022; 13():922315. PubMed ID: 35774794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.
    Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ
    Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis-related gene model to predict overall survival of papillary thyroid carcinoma.
    Yang D; Wang J; Li C; Shi L; Zhang M
    Am J Otolaryngol; 2021; 42(6):103163. PubMed ID: 34339960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
    Guo K; Chen L; Wang Y; Qian K; Zheng X; Sun W; Sun T; Wu Y; Wang Z
    Cancer Med; 2019 Jun; 8(6):3105-3119. PubMed ID: 31044550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cell cycle-related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma.
    Li S; Ran MY; Qiao H
    Front Endocrinol (Lausanne); 2023; 14():1110987. PubMed ID: 36923215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer.
    Lin Y; Gan F; He X; Deng H; Li Y
    J Immunol Res; 2022; 2022():5893998. PubMed ID: 35915656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
    Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
    Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model.
    Xiang X; Guo Y; Chen Z; Zhang F; Qin Y
    Cancer Biomark; 2023; 37(2):95-107. PubMed ID: 37248883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods.
    Xiong Y; Ouyang Y; Fang K; Sun G; Tu S; Xin W; Wei Y; Xiao W
    Comput Math Methods Med; 2022; 2022():4558782. PubMed ID: 35774297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
    Gu Y; Feng C; Liu T; Zhang B; Yang L
    PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.